CRISPR Gene Therapy for Sickle Cell Disease and Beta-Thalassaemia
In our 14 August 2022 edition, we discussed many therapeutic approaches to treating sickle cell disease (SCD), including the use of haematopoietic stem cells (HSCs) gene therapy. This revolutionary treatment involved harvesting and genetically modifying the sickle cells in the laboratory. The
Follow Us